Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT02053493
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Registry
-
NCT02053493
-
- Other papers using this trial's data
- Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices
- Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02053493. Randomized; triple masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2015-02 (actual). Results posted on 2016-11-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
- Acronym
- NEAT-HFpeF
- Condition
- Heart Failure
- Intervention (Drug)
- Isosorbide Mononitrate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Adrian Hernandez
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- Mayo Clinic
- Collaborator
- University of Vermont
Record details
- Record id
cardio:ct-nct02053493- Content hash
ab3b58d12cc61c5a9a527c135ad7b602bd106353f3d79eac0cd04a2cd9a9fc0c